Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysis
Open Access
- 3 December 2024
- journal article
- Published by Bentham Science Publishers Ltd. in Clinical Practice & Epidemiology in Mental Health
- Vol. 20 (1)
Abstract
Background: Many pharmacological treatments are considered effective in the treatment of panic disorder (PD), however, about 20 to 40% of the patients have treatment-resistant PD. Pharmacogenetics could explain why some patients are treatment-resistant. Objective: Our objective was to gather preliminary data on the clinical usefulness of pharmacogenetic testing in this disorder. Methods: Twenty patients with treatment-resistant PD were included in this observational study and submitted to commercial pharmacogenetic testing. Testing panel included gene polymorphisms related to CYP, genes EPHX1, UGT1A4, UGT2B15, ABCB1, ADRA2A, ANKK1, COMT, DRD2, FKBP5, GRIK4, GSK3B, HTR1A, HTR2A, HTR2C, MC4R, OPRM1, SCN1A, SLC6A4 and MTHFR. Participants received treatment-as-usual for PD before being enrolled in this study, including first-line and second-line medications for PD. Results: In 30% of the patients, the tests indicated reduced chance of response to the prescribed drug, while they indicated very low serum levels of the prescribed drug in 20% of the subjects. The pharmacogenetic tests predicted reduction of MTHFR enzyme activity in 74% of the patients. ABCB1 gene alleles associated to drug resistance were found in 90% of the samples. Conclusion: Commercial pharmacogenetic testing failed to predict negative treatment outcome in most patients with PD. The association between treatment-resistance in PD and the genes CYP2C19, MTHFR and ABCB1 deserves further study.Keywords
This publication has 43 references indexed in Scilit:
- Pharmacogenetics of anxiety disordersNeuroscience Letters, 2020
- Adjunctive folate for major mental disorders: A systematic reviewJournal of Affective Disorders, 2020
- Antidepressants versus placebo for panic disorder in adultsCochrane Database of Systematic Reviews, 2018
- AUGMENTATION STRATEGIES FOR TREATMENT-RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSISDepression and Anxiety, 2016
- Mutation Update and Review of Severe Methylenetetrahydrofolate Reductase DeficiencyHuman Mutation, 2016
- Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Treatment-Resistant Panic DisorderCNS Spectrums, 2004
- Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and GermanyNeuroscience Letters, 2004
- Folate, Vitamin B12, Homocysteine, and the MTHFR 677C→T Polymorphism in Anxiety and DepressionArchives of General Psychiatry, 2003
- Genetics of blood-injury fears and phobias: A population-based twin studyAmerican Journal of Medical Genetics, 1994